Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
Abstract
The prevention of bleeding with adequately sustained levels of clotting factor, after a single therapeutic intervention and without the need for further medical intervention, represents an important goal in the treatment of...
Paper Details
Title
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
Published Date
Dec 7, 2017
Volume
377
Issue
23
Pages
2215 - 2227
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History